Literature DB >> 1487472

Emergence of obsessive compulsive symptoms during treatment with clozapine.

R W Baker1, K N Chengappa, J W Baird, S Steingard, M A Christ, N R Schooler.   

Abstract

BACKGROUND: Clozapine differs from other currently available antipsychotics in its prominent serotonin blockade. We explore the relationship between clozapine and obsessive compulsive symptoms, which have been linked to deficient serotonin.
METHOD: We reviewed our experience in treating 49 chronic schizophrenic patients with clozapine.
RESULTS: Five patients were identified who experienced either de novo obsessive compulsive symptoms or exacerbation of preexistent symptoms. Clinical details are provided for each case.
CONCLUSION: Clozapine may produce or unmask obsessive compulsive symptoms. This may reflect a variation on the normal course of clinical improvement, or may more specifically result from clozapine's atypical pattern of CNS receptor antagonism. Further attention to this issue is warranted.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487472

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  24 in total

1.  Dramatic weight loss associated with commencing clozapine.

Authors:  John Lally; Colm McDonald
Journal:  BMJ Case Rep       Date:  2011-11-08

Review 2.  Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: a review of the experimental literature.

Authors:  Trehani M Fonseka; Margaret A Richter; Daniel J Müller
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

3.  Interventions for obsessive compulsive symptoms in people with schizophrenia.

Authors:  Mohan Raj; Saeed Farooq
Journal:  Cochrane Database Syst Rev       Date:  2005

4.  Haloperidol induced obsessive compulsive symptom (OCS) in a patient with learning disability and bipolar affective disorder.

Authors:  Inam Ulhaq; Adam Abba-Aji
Journal:  BMJ Case Rep       Date:  2012-03-08

5.  Elevated plasma levels of clozapine after concomitant use of fluvoxamine.

Authors:  M Heeringa; R Beurskens; W Schouten; M M Verduijn
Journal:  Pharm World Sci       Date:  1999-10

6.  Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study.

Authors:  Giulio Perugi; Franco Frare; Cristina Toni; Giuseppe Tusini; Giulia Vannucchi; Hagop S Akiskal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-03-18       Impact factor: 5.270

Review 7.  Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap.

Authors:  P Tibbo; L Warneke
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

Review 8.  The genetic studies of obsessive-compulsive disorder and its future directions.

Authors:  Se Joo Kim; Chan-Hyung Kim
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

9.  Transmission disequilibrium studies in early onset of obsessive-compulsive disorder for polymorphisms in genes of the dopaminergic system.

Authors:  Susanne Walitza; André Scherag; Tobias J Renner; Anke Hinney; Helmut Remschmidt; Beate Herpertz-Dahlmann; Eberhard Schulz; Helmut Schafer; Klaus W Lange; Christoph Wewetzer; Manfred Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2008-04-30       Impact factor: 3.575

10.  Clozapine-induced dysphagia with secondary substantial weight loss.

Authors:  Mugtaba Osman; Vekneswaran Devadas
Journal:  BMJ Case Rep       Date:  2016-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.